TP53 and B-cell chronic lymphocytic leukemia: Structural information on SNX-7081 seems to be unavailable, but it appears effective in sensitizing fludarabine for the treatment of p53-negative chronic lymphocytic leukemia (CLL) by enhancing DNA damage and impairing DNA repair mechanisms[92].